Skip to main content
. Author manuscript; available in PMC: 2014 Jan 7.
Published in final edited form as: Pharm Res. 2010 Apr 6;27(6):10.1007/s11095-010-0113-y. doi: 10.1007/s11095-010-0113-y

Table 1.

NF-κB Descriptive Statistics for the 9 Intervention Compliant Subjects

Time point Median Mean 80% CI lower limit for the mean 80% CI upper limit for the mean SD Min. Max.
Pre-intevention (−) TNF-α 19.39 46.32 13.21 79.43 71.21 8.14 232.04
(+) TNF-α 27.49 61.08 16.03 106.14 96.76 11.80 314.51
Differencea 5.82 14.76* 2.59 26.94 26.15 −1.89 82.47
(−) TNF-α Pre 19.39 46.32 13.21 79.43 71.12 8.14 232.04
Post 19.41 38.64 11.86 65.42 57.52 5.23 189.08
Differenceb −3.46 −7.68** −14.26 −1.09 14.15 −42.96 1.74
(+)TNF-α Pre 27.49 61.08 16.03 106.14 96.76 11.80 314.51
Post 19.32 35.73 11.87 59.59 51.25 8.49 170.57
Differencec −7.60 −25.36* −46.65 −4.06 45.74 −143.94 0.76
*

P =.0195;

**

P =.0547. Units for all statistics in table are arbitrary units of optical density (OD).

CI = confidence interval (for the true mean).

a

Difference* = (After TNF-α - Before TNF-α);

b

Difference** = (Post-intervention - Pre-intervention);

c

Difference* = (Postintervention - Pre-intervention).